REGENLIFE has a total of 17 patent applications. It increased the IP activity by 800.0%. Its first patent ever was published in 2016. It filed its patents most often in EPO (European Patent Office), France and Australia. Its main competitors in its focus markets medical technology, telecommunications and digital networks are WEISBART PAUL, ZABARA JACOB and PITMAN MICHAEL J.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | France | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | United States | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Telecommunications | |
#3 | Digital networks |
# | Technology | |
---|---|---|
#1 | Electrotherapy | |
#2 | Transmission systems | |
#3 | Digital information transmission |
# | Name | Total Patents |
---|---|---|
#1 | Blivet Guillaume | 16 |
#2 | Moreau Guillaume | 16 |
#3 | Cochard Etienne | 9 |
Publication | Filing date | Title |
---|---|---|
CN110831661A | Percutaneous irradiation device and application to treatment of neurodegenerative diseases | |
EP3527259A1 | Optical guide for visible radiation diffusion, module and device for transcutaneous irradiation, in particular transcranial irradiation | |
FR3065165A1 | Transcutaneous irradiation device and application to the treatment of neurodegenerative diseases | |
EP3315169A1 | Mounting for transcutaneous irradiation modules and associated device |